Category: Company Announcements

Industry Thought Leader Darius Pillsbury Joins ValSource

Darius Pillsbury has joined ValSource as a Senior Consultant. He brings more than 25 years of industry experience in biopharmaceutical manufacturing.

View Post

The Medicine Maker 2019 Power List

Congratulations to ValSource Chief Operating Officer Hal Baseman on being named an industry influencer by The Medicine Maker.

View Post

Industry Thought Leader Stephen Langille Joins ValSource

Stephen (“Steve”) Langille has joined ValSource as a Senior Microbiology Consultant. Steve brings nearly 20 years of high-level industry experience to the ValSource consulting team.

View Post

Paula Peacos Joins ValSource

Paula brings more than 25 years of industry experience to ValSource in aseptic processing of parenterals, and in the manufacture of nonsterile oral solid dosage, biological drug substances and APIs at clinical and commercial production.

View Post

ValSource Consultant Chris Smalley Honored by Parenteral Drug Association

Chris Smalley, an experienced sterile compounding pharmacist, works with pharmacists to design, build and operate compliant compounding facilities. His service to PDA includes 16 years on the PDA Science Advisory Board, two terms on the Board of Directors, and 12 years leading the Facilities & Engineering Interest Group.

View Post

Senior Consultant Kelly Waldron Earns PhD

Senior Consultant Kelly Waldron has earned a PhD in Pharmaceutical Regulatory Science, with a specialization in Quality Risk Management (“QRM”), from the Dublin Institute of Technology, Ireland. Research for Waldron’s thesis, “Managing Risk to the Patient: Recoding Quality Risk Management for the Pharmaceutical and Biopharmaceutical Industries” spanned three years and included insight from multiple industry regulators, QRM practitioners, and the Parenteral Drug Association (“PDA”).

Kelly’s research focused on defining how a QRM program should be designed and deployed to deliver value in an effective and efficient way….

View Post

Whitney Kutney Named Vice President

ValSource, LLC today announced Whitney Kutney now heads ValSource operations as Vice President. ValSource, together with Engineering Software Solutions, LLC and ConcordiaValsource, LLC make up the ValSource family of companies.

“This move is a reflection of the overall strength of our managers and employees,” noted ValSource management. “It allows the company to continue focusing on strategic growth opportunities, further positioning ValSource to support its clientele with existing, new and enhanced services.”

Whitney Kutney has been with ValSource since March 2003….

View Post

ValSource Announces Rapid Response Team

ValSource today announced the ValSource Rapid Response Team. The team is a fast action, fast response group for clients needing to promptly address regulatory and compliance citation matters. The team was developed and strategically staffed to quickly mobilize and respond within the short time frames required for regulatory matters.

The team is comprised of ValSource’s senior knowledge group that includes specialists in microbiology, contamination prevention, process control, validation, data integrity, training, quality risk management, regulatory expectations and overall quality system implementation….

View Post

ValSource Experts Present on Global Sterile Product Manufacturing

Chief Operating Officer Hal Baseman and Director of Learning Solutions James Vesper are featured presenters at the 2017 Parenteral Drug Association Annex 1 Workshop. The workshop, being held October 2-3 at the Omni Shoreham Hotel in Washington, D.C., is designed to present the newly released draft revision to EU Annex 1, Manufacture of Sterile Medicinal Products of the European Union Guidelines to Good Manufacturing Practice of Medicinal Products for Human and Veterinary Use.

“Make no mistake….

View Post

ValSource Consultant Chris Smalley Appointed to House of Delegates

Compounding Pharmacy Consultant Christopher (Chris) J. Smalley has been appointed to the American Pharmacists Association (APhA) House of Delegates (HOD) as a delegate for the Academy of Pharmaceutical Research and Science. “This role presents authentic opportunities to inform the Association’s policy development process around compounding pharmacy,” Smalley commented. “Through networking and policy-related activities leading up to the House of Delegates meeting, I hear firsthand the new and exciting developments our clients and industry face. I’m able to advocate solutions borne of ValSource’s tailored, risk-based approaches to hospital pharmacies and compounding centers.”

The HOD is the principal policy-making body of the APhA….

View Post